

          1. Cases of severe vomiting that make it difficult to take the drug orally

          2. Allergic to Favipiravir or tocilizumab

          3. Pregnant and lactating women

          4. Subjects received specific antiviral drugs such as lopinavir / ritonavir, ribavirin,
             arbidol, chloroquine phosphate, hydroxychloroquine, and monoclonal antibodies within
             one week before admission.

          5. Cases of respiratory failure and requiring mechanical ventilation

          6. Cases of shock

          7. Combined organ failure requires ICU monitoring and treatment

          8. Predicted clinically that there is no hope of survival, or cases of deep coma that do
             not respond to supportive treatment measures within three hours of admission

          9. Alanine aminotransferase / Aspartate aminotransferase> 5 times of upper limit of
             normal

         10. Neutrophils <0.5  10^9 / L, platelets less than 50  10^9 / L

         11. Clear diagnosis of rheumatoid immunity, malignant tumors and other related diseases

         12. Long-term oral anti-rejection drugs or immunomodulatory drugs

         13. Allergic reactions to tocilizumab or any excipients

         14. Patients with active hepatitis, tuberculosis, and definite bacterial and fungal
             infections

         15. Organ transplant patients

         16. Patients with mental disorders
      